DE69125940T2 - Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten - Google Patents

Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten

Info

Publication number
DE69125940T2
DE69125940T2 DE69125940T DE69125940T DE69125940T2 DE 69125940 T2 DE69125940 T2 DE 69125940T2 DE 69125940 T DE69125940 T DE 69125940T DE 69125940 T DE69125940 T DE 69125940T DE 69125940 T2 DE69125940 T2 DE 69125940T2
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
benzimidazole
difluormethoxy
heliobacter
methylsulfinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69125940T
Other languages
English (en)
Other versions
DE69125940D1 (de
Inventor
Michael Parsons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10681166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69125940(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of DE69125940D1 publication Critical patent/DE69125940D1/de
Application granted granted Critical
Publication of DE69125940T2 publication Critical patent/DE69125940T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69125940T 1990-08-24 1991-08-23 Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten Expired - Lifetime DE69125940T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909018603A GB9018603D0 (en) 1990-08-24 1990-08-24 Compositions
PCT/GB1991/001427 WO1992003135A1 (en) 1990-08-24 1991-08-23 Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders

Publications (2)

Publication Number Publication Date
DE69125940D1 DE69125940D1 (de) 1997-06-05
DE69125940T2 true DE69125940T2 (de) 1997-12-18

Family

ID=10681166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125940T Expired - Lifetime DE69125940T2 (de) 1990-08-24 1991-08-23 Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten

Country Status (13)

Country Link
EP (1) EP0544760B1 (de)
JP (1) JPH06503806A (de)
KR (1) KR930701166A (de)
AT (1) ATE152350T1 (de)
AU (1) AU658831B2 (de)
CA (1) CA2089748C (de)
CY (1) CY2167B1 (de)
DE (1) DE69125940T2 (de)
DK (1) DK0544760T3 (de)
ES (1) ES2103825T3 (de)
GB (1) GB9018603D0 (de)
GR (1) GR3024058T3 (de)
WO (1) WO1992003135A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
WO1994013290A1 (de) * 1992-12-10 1994-06-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von alkylthiopyridinen zur bekämpfung von heliobacter-bakterien
WO1994027606A1 (en) * 1993-05-28 1994-12-08 Unisearch Limited Method of treating helicobacter pylori infection
ATE192932T1 (de) * 1993-09-09 2000-06-15 Takeda Chemical Industries Ltd Formulierung enthaltend einen antibakteriellen und einen antiulcus wirkstoff
TW420610B (en) * 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5861518A (en) * 1994-11-21 1999-01-19 Dekker; Koenraad A. Phthalide compounds and their production process
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
EP1003554B1 (de) 1997-07-25 2004-11-03 ALTANA Pharma AG Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
EP2601947A1 (de) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Kombinationspräparat mit fester Dosierung zur Behandlung von Erkrankungen einhergehend mit Helicobacter pylori

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3887353T2 (de) * 1987-10-12 1994-05-05 Exomed Australia Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
AU8424091A (en) 1992-03-17
WO1992003135A1 (en) 1992-03-05
EP0544760A1 (de) 1993-06-09
ATE152350T1 (de) 1997-05-15
CA2089748A1 (en) 1992-02-25
GB9018603D0 (en) 1990-10-10
DK0544760T3 (da) 1997-09-22
DE69125940D1 (de) 1997-06-05
KR930701166A (ko) 1993-06-11
GR3024058T3 (en) 1997-10-31
CA2089748C (en) 2005-07-05
AU658831B2 (en) 1995-05-04
ES2103825T3 (es) 1997-10-01
CY2167B1 (en) 2002-08-23
EP0544760B1 (de) 1997-05-02
JPH06503806A (ja) 1994-04-28

Similar Documents

Publication Publication Date Title
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3382641T2 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
LV10577A (lv) Omeprazola ka antimikrobu lidzekla lietosana
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE69125940T2 (de) Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
DE68929388T2 (de) Aus Harn isolierte antikoagulierende Verbindung
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
SE8804628D0 (sv) New compounds
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ES2060293T3 (es) Nueva sustancia antiulcerosa.
DE68903059D1 (de) Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
DE68916651T2 (de) Heilmittel zur behandlung von toxoplasmose.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
DE68916443T2 (de) Arzneimittel zur behandlung von kryptosporidiose.
DE68920022D1 (de) Indolessigsäure-derivate, verfahren zur herstellung sowie arzneimittel, die diese als aktive mittel enthalten.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.

Legal Events

Date Code Title Description
V448 Application of spc

Free format text: PRODUCT NAME: PANTOPRAZOL SOWIE SEINE SALZE UND HYDRATE VON PANTOPRAZOL UND SEINEN SALZEN IN KOMBINATION MIT CLARITHROMYCIN UND AMOXICILLIN ODER CLARITHROMYCIN UND METRONIDAZOL ODER AMOXICILLIN UND METRONIDAZOL; REGISTRATION NO/DATE: 40718.00.00, 19970805

Spc suppl protection certif: 198 75 006

Filing date: 19980130

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ALTANA PHARMA AG, 78467 KONSTANZ, DE

V472 Application for supplementary protection certificate rejected

Free format text: PRODUCT NAME: PANTOPRAZOL SOWIE SEINE SALZE UND HYDRATE VON PANTOPRAZOL UND SEINEN SALZEN IN KOMBINATION MIT CLARITHROMYCIN UND AMOXICILLIN ODER CLARITHROMYCIN UND METRONIDAZOL ODER AMOXICILLIN UND METRONIDAZOL; REGISTRATION NO/DATE: 40718.00.00, 19970805

Spc suppl protection certif: 198 75 006

Filing date: 19980130

8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE